SARS in Hong Kong.
Wu
Ya Ping
YP
Wei
Ran
R
de Groot
Philip G
PG
D000925:Anticoagulants / Q000627:therapeutic use; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis*; D006801:Humans; D010314:Partial Thromboplastin Time; D045169:Severe Acute Respiratory Syndrome / Q000097:blood* / Q000188:drug therapy; D013921:Thrombocytopenia / Q000209:etiology
D000925:Anticoagulants; D005338:Fibrin Fibrinogen Degradation Products; C036309:fibrin fragment D